Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone vs Triamcinolone for Sacroiliac Joint Injection
NCT03166761Phase 4Terminated
- Sponsor
- Vanderbilt University Medical Center
- Start
- Sep 2017
- Primary completion
- Feb 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexamethasone in Osteoarthritis of the sacroiliac joint (2 arms), sponsored by Vanderbilt University Medical Center. Primary endpoint: Numeric Pain Rating Score at 3 months. Started Sep 2017; status: terminated.
02
Drugs
dexamethasone
03
Conditions
Osteoarthritis of the sacroiliac joint
Beyond the preview
Go deeper on NCT03166761.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03166761.